9
Views
51
CrossRef citations to date
0
Altmetric
Mammalian Genetic Models with Minimal or Complex Phenotypes

Disruption of γ-Glutamyl Leukotrienase Results in Disruption of Leukotriene D4 Synthesis In Vivo and Attenuation of the Acute Inflammatory Response

, , , &
Pages 5389-5395 | Received 03 Apr 2001, Accepted 23 May 2001, Published online: 28 Mar 2023

REFERENCES

  • Bradley, P. P., D. A. Priebat, R. D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Investig. Dermatol. 78:206–209.
  • Buckner, C. K., R. D. Krell, R. B. Laravuso, D. B. Coursin, P. R. Bernstein, and J. A. Will. 1986. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4. J. Pharmacol. Exp. Ther. 237:558–562.
  • Byrum, R. S., J. L. Goulet, J. N. Snouwaert, R. J. Griffiths, and B. H. Koller. 1999. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J. Immunol. 163:6810–6819.
  • Carter, B. Z., A. L. Wiseman, R. Orkiszewski, K. D. Ballard, C. N. Ou, and M. W. Lieberman. 1997. Metabolism of leukotriene C4 in γ-glutamyl transpeptidase-deficient mice. J. Biol. Chem. 272:12305–12310.
  • Carter, B. Z., Z. Z. Shi, R. Barrios, and M. W. Lieberman. 1998. γ-Glutamyl leukotrienase, a γ-glutamyl transpeptidase gene family member, is expressed primarily in spleen. J. Biol. Chem. 273:28277–28285.
  • Chen, X.-S., J. R. Sheller, E. N. Johnson, and C. D. Funk. 1994. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372:179–182.
  • Chevez-Barrios, P., A. L. Wiseman, E. Rojas, C. N. Ou, and M. W. Lieberman. 2000. Cataract development in γ-glutamyl transpeptidase-deficient mice. Exp. Eye Res. 71:575–582.
  • Devillier, P., N. Baccard, and C. Advenier. 1999. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma. Pharmacol. Res. 40:3–13.
  • Devillier, P., N. Baccard, and C. Advenier. 1999. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma. Pharmacol. Res. 40:15–29.
  • Doherty, N. S., P. Poubelle, P. Borgeat, T. H. Beaver, G. L. Westrich, and N. L. Schrader. 1985. Intraperitoneal injection of Zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2. Prostaglandins 30:769–789.
  • Drazen, J. M.. 1988. Comparative contractile responses to sulfidopeptide leukotrienes in normal and asthmatic human subjects. Ann. N. Y. Acad. Sci. 524:289–297.
  • Goulet, J. L., R. S. Byrum, M. L. Key, M. Nguyen, V. A. Wagoner, and B. H. Koller. 2000. Genetic factors determine the contribution of leukotrienes to acute inflammatory responses. J. Immunol. 164:4899–4907.
  • Goulet, J. L., J. N. Snouwaert, A. M. Latour, T. M. Coffman, and B. H. Koller. 1994. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA 91:12852–12856.
  • Habib, G. M., and M. W. Lieberman. 1999. Cleavage of leukotriene D4 in mice with targeted disruption of a membrane-bound dipeptidase gene. Adv. Exp. Med. Biol. 469:295–300.
  • Habib, G. M., Z. Z. Shi, A. A. Cuevas, Q. Guo, M. M. Matzuk, and M. W. Lieberman. 1998. Leukotriene D4 and cystinyl-bis-glycine metabolism in membrane-bound dipeptidase-deficient mice. Proc. Natl. Acad. Sci. USA 95:4859–4863.
  • Heise, C. E., B. F. O'Dowd, D. J. Figueroa, N. Sawyer, T. Nguyen, D. S. Im, R. Stocco, J. N. Bellefeuille, M. Abramovitz, R. Cheng, D. L. Williams Jr., Z. Zeng, Q. Liu, L. Ma, M. K. Clements, N. Coulombe, Y. Liu, C. P. Austin, S. R. George, G. P. O'Neill, K. M. Metters, K. R. Lynch, and J. F. Evans. 2000. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275:30531–30536.
  • Henderson, W. R. Jr.. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 183:1–5.
  • Hogaboom, G. K., S. Mong, H. L. Wu, and S. T. Crooke. 1983. Peptidoleukotrienes: distinct receptors for leukotriene C4 and D4 in the guinea-pig lung. Biochem. Biophys. Res. Commun. 116:1136–1143.
  • Holgate, S. T., P. Bradding, and A. P. Sampson. 1996. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J. Allergy Clin. Immunol. 98:1–13.
  • Horwitz, R. J., K. A. McGill, and W. W. Busse. 1998. The role of leukotriene modifiers in the treatment of asthma. Am. J. Respir. Crit. Care Med. 157:1363–1371.
  • Kanwar, S., B. Johnston, and P. Kubes. 1995. Leukotriene C4/D4 induces P-selectin and sialyl Lewisx-dependent alterations in leukocyte kinetics in vivo. Circ. Res. 77:879–887.
  • Kumar, T. R., A. L. Wiseman, G. Kala, S. V. Kala, M. M. Matzuk, and M. W. Lieberman. 2000. Reproductive defects in γ-glutamyl transpeptidase-deficient mice. Endocrinology 141:4270–4277.
  • Lieberman, M. W., A. L. Wiseman, Z. Z. Shi, B. Z. Carter, R. Barrios, C. N. Ou, P. Chevez-Barrios, Y. Wang, G. M. Habib, J. C. Goodman, S. L. Huang, R. M. Lebovitz, and M. M. Matzuk. 1996. Growth retardation and cysteine deficiency in γ-glutamyl transpeptidase-deficient mice. Proc. Natl. Acad. Sci. USA 93:7923–7926.
  • Lieberman, M. W., J. E. Shields, Y. Will, D. J. Reed, and B. Z. Carter. 1999. γ-Glutamyl leukotrienase cleavage of leukotriene C4. Adv. Exp. Med. Biol. 469:301–306.
  • Liu, D., M. M. Matzuk, W. K. Sung, Q. Guo, P. Wang, and D. J. Wolgemuth. 1998. Cyclin A1 is required for meiosis in the male mouse. Nat. Genet. 20:377–380.
  • Lynch, K. R., G. P. O'Neill, Q. Liu, D. S. Im, N. Sawyer, K. M. Metters, N. Coulombe, M. Abramovitz, D. J. Figueroa, Z. Zeng, B. M. Connolly, C. Bai, C. P. Austin, A. Chateauneuf, R. Stocco, G. M. Greig, S. Kargman, S. B. Hooks, E. Hosfield, D. L. Williams Jr., A. W. Ford-Hutchinson, C. T. Caskey, and J. F. Evans. 1999. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399:789–793.
  • Meister, A., and A. Larsson. 1995. Glutathione synthesis deficiency and other disorders of the γ-glutamyl cycle. The metabolic basis of inherited diseases, 7th ed. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle. 1461–1477. McGraw-Hill Book Co., New York, N.Y
  • Orning, L., and S. Hammarstrom. 1980. Inhibition of leukotriene C and leukotriene D biosynthesis. J. Biol. Chem. 255:8023–8026.
  • Pong, S. S., R. N. DeHaven, F. A. Kuehl Jr., and R. W. Egan. 1983. Leukotriene C4 binding to rat lung membranes. J. Biol. Chem. 258:9616–9619.
  • Rao, T. S., J. L. Currie, A. F. Shaffer, and P. C. Isakson. 1994. In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther. 269:917–925.
  • Sarau, H. M., R. S. Ames, J. Chambers, C. Ellis, N. Elshourbagy, J. J. Foley, D. B. Schmidt, R. M. Muccitelli, O. Jenkins, P. R. Murdock, N. C. Herrity, W. Halsey, G. Sathe, A. I. Muir, P. Nuthulaganti, G. M. Dytko, P. T. Buckley, S. Wilson, D. J. Bergsma, and D. W. Hay. 1999. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol. Pharmacol. 56:657–663.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.